Researchers from the Massachusetts Institute of Technology, the Broad Institute of MIT and Harvard, the Whitehead Institute for Biomedical Research, and Massachusetts General Hospital have analyzed the interactions between 35 different types of nanoparticles and nearly 500 types of cancer cells, revealing thousands of biological traits that influence whether those cells take up different types of nanoparticles. The findings could help researchers better tailor their drug-delivery nanoparticles to specific types of cancer, or design new nanoparticles that take advantage of the biological features of particular types of cancer cells.
An official website of the United States government.